In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Enforcement, Not Promotion, May See First Changes After Free Speech Ruling

Executive Summary

In a watershed decision, a federal appeals court declares that manufacturers cannot be prosecuted under the FD&C Act’s misbranding provisions solely for speech promoting off-label use of a drug. Industry attorneys predict the decision, if it stands, will change the government’s approach to pursuing such cases.

You may also be interested in...



Off-Label Use Discussions Should Stay Off-line, FDA Draft Guidance Says

FDA advises companies to respond to unsolicited requests for off-label information in one-on-one dialogue; the agency also requests public comments on its policies regarding off-label communications in response to an industry citizen petition.

Sales Rep's Free Speech Challenge Of Off-Label Regs Boosted By Sorrell Ruling

The Supreme Court's ruling that Vermont's prescriber data mining law violates the First Amendment could help a pharma sales representative to overturn his conviction for promoting a drug for off-label uses.

FDA Pressed To Clarify Permissible Formulary, Clinical Guideline Communications

Citizen petition from seven firms asks agency to issue regulations related to four areas of off-label communications.

Related Content

Topics

UsernamePublicRestriction

Register

IV003785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel